D.E. Shaw & Co
DMII

D.E. Shaw & Co’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

D.E. Shaw & Co’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8M Buy
1,475,000
+84,900
+6% +$852K 0.01% 1515
2026
Q1 		$13.9M Buy
1,390,100
+390,100
+39% +$3.89M 0.01% 1391
2025
Q4 		$9.9M Buy
+1,000,000
New +$9.89M 0.01% 1767

Other funds holding DMII

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

D.E. Shaw & Co's DMII Position: Q2 2026 in Review

D.E. Shaw & Co increased its Drugs Made In America Acquisition II Corp (DMII) stake by 6.1% in Q2 2026, buying an estimated $852K and bringing the position to 1,475,000 shares worth $14.8M. The position accounts for 0.01% of the portfolio, ranked #1515.

D.E. Shaw & Co first reported a position in DMII in Q4 2025 and has held it in 3 quarters since. 69 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • D.E. Shaw & Co held 1,475,000 shares of Drugs Made In America Acquisition II Corp worth $14.8M as of Q2 2026.
  • D.E. Shaw & Co bought 84,900 Drugs Made In America Acquisition II Corp shares in Q2 2026, an estimated $852K.
  • Drugs Made In America Acquisition II Corp made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1515 holding.
  • D.E. Shaw & Co first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 3 quarters since.
  • 69 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.